Kerry Holford
Stock Analyst at Berenberg Bank
(3.80)
# 1,908
Out of 4,407 analysts
232
Total ratings
53.6%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Kerry Holford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Maintained: Hold | $25 | $26.21 | -4.62% | 30 | May 8, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 2,000p | $1,984.00 | +0.81% | 49 | May 5, 2026 | |
| LLY Eli Lilly and Company | Maintained: Hold | $950 → $1,050 | $1,133.00 | -7.33% | 29 | Apr 21, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Buy | kr 360.00 → kr 300.00 | $283.55 | +5.80% | 40 | Mar 12, 2026 | |
| NVO Novo Nordisk | Maintained: Buy | $57 → $47 | $43.88 | +7.11% | 7 | Mar 11, 2026 | |
| NVS Novartis AG | Rated: Hold | $116 → $141 | $153.07 | -7.89% | 8 | Mar 6, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $132 → $128 | $44.70 | +186.42% | 3 | Dec 4, 2025 | |
| GSK GSK plc | Maintained: Hold | $41 → $43 | $53.04 | -18.93% | 14 | Nov 25, 2025 | |
| SWX: NOVN Novartis AG | Maintained: Hold | CHF 89.00 → CHF 92.00 | $122.08 | -24.64% | 40 | Nov 18, 2025 | |
| EPA: SAN Sanofi | Maintained: Buy | €105.00 → €120.00 | $76.59 | n/a | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €1.60 | $1.95 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $89.68 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 100p | $39.50 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €105.00 → €130.00 | $273.80 | n/a | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €150.00 | $133.25 | n/a | 1 | Apr 16, 2021 |
Pfizer
May 8, 2026
Maintained: Hold
Price Target: $25
Current: $26.21
Upside: -4.62%
GSK plc
May 5, 2026
Maintained: Hold
Price Target: 2,000p
Current: $1,984.00
Upside: +0.81%
Eli Lilly and Company
Apr 21, 2026
Maintained: Hold
Price Target: $950 → $1,050
Current: $1,133.00
Upside: -7.33%
Novo Nordisk A/S
Mar 12, 2026
Maintained: Buy
Price Target: kr 360.00 → kr 300.00
Current: $283.55
Upside: +5.80%
Novo Nordisk
Mar 11, 2026
Maintained: Buy
Price Target: $57 → $47
Current: $43.88
Upside: +7.11%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: $116 → $141
Current: $153.07
Upside: -7.89%
Zealand Pharma A/S
Dec 4, 2025
Maintained: Buy
Price Target: $132 → $128
Current: $44.70
Upside: +186.42%
GSK plc
Nov 25, 2025
Maintained: Hold
Price Target: $41 → $43
Current: $53.04
Upside: -18.93%
Novartis AG
Nov 18, 2025
Maintained: Hold
Price Target: CHF 89.00 → CHF 92.00
Current: $122.08
Upside: -24.64%
Sanofi
May 16, 2025
Maintained: Buy
Price Target: €105.00 → €120.00
Current: $76.59
Upside: n/a
Apr 1, 2025
Maintained: Hold
Price Target: €1.60
Current: $1.95
Upside: n/a
Mar 24, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $89.68
Upside: n/a
Mar 24, 2025
Maintained: Buy
Price Target: 100p
Current: $39.50
Upside: n/a
Apr 11, 2024
Maintained: Buy
Price Target: €105.00 → €130.00
Current: $273.80
Upside: n/a
Apr 16, 2021
Maintained: Hold
Price Target: €150.00
Current: $133.25
Upside: n/a